Ventas, Inc. (NYSE:VTR) is on recovery track with 34.46% gain from a 1-year low price of $51.8. The company added 1.53% to attain the price of $69.65 on 6/19/2019. Throughout the recent session, the prices were hovering between $67.89 and $69.95. These shares are -9.55% up from its target price of $63 and the current market capitalization stands at $25.33B. The recent change has given its price a 10.73% lead over SMA 50 and 0.84% lead over its 52-week high. The stock witnessed 8.64% gains, 12.92% gains and 14.42% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found VTR’s volatility during a week at 2.22% and during a month it has been found around 1.7%.

What Does Ventas, Inc. (VTR) Do?

The company describes itself in regulatory filings as, “Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. The company invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operate them through independent third-party managers. It operates through the following segments: Triple-Net Leased Properties, Senior Living Operations, and Office Operations. The company was founded in 1983 and is headquartered in Chicago, IL.” [Text can be found here: under company description.]

Ventas, Inc. (VTR) Top Holders

Institutional investors currently hold around $21.66 billion or 88.9% in VTR stock. Look at its top three institutional owners: Vanguard Group Inc owns $3.21 billion in Ventas, Inc., which represents roughly 12.67% of the company’s market cap and approximately 14.81% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 36,891,328 shares of the stock are valued at $2.53 billion. The third largest holder is State Street Corp, which currently holds $1.67 billion worth of this stock and that ownership represents nearly 6.58% of its market capitalization.

Ventas, Inc. 13F Filings

At the end of March reporting period, 366 institutional holders increased their position in Ventas, Inc. (NYSE:VTR) by some 24,133,373 shares, 336 decreased positions by 24,404,163 and 104 held positions by 267,234,676. That puts total institutional holdings at 315,772,212 shares, according to SEC filings. The stock grabbed 82 new institutional investments totaling 1,328,287 shares while 49 institutional investors sold out their entire positions totaling 1,195,409 shares.

Ventas, Inc. (NYSE:VTR) Insider Trades

Multiple company employees have indulged in significant insider trading. Ventas, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chairman and CEO CAFARO DEBRA A has sold 68,084 shares of Ventas, Inc. (VTR) in the trading session dated Jun. 14, 2019. These shares are worth $4,530,309 and were traded at $66.54 each. The SEC filing shows that Cobb John D. performed a sale of 10,000 shares. The EVP, Chief Investment Off. disposed these shares by way of transaction on Mar. 28, 2019. The company’s shares were given away at $64.88 per share worth to an income of some $648,800 to the account of Cobb John D..

Director, SHELTON JAMES D, sold 5,940 common shares of Ventas, Inc. (VTR) in the open market. In a transaction dated Mar. 28, 2019, the shares were put up for sale at an average price of $64.79, raking in a sum of $384,853. After this sale, 40,920 common shares of VTR are directly owned by the insider, with total stake valued at $2,850,100.

In the transaction dated Mar. 22, 2019, a great number of shares sold came courtesy the Director; Reed Robert D. disposed a total of 3,440 shares at an average price of $63.89, amounting to approximately $219,782. The insider now directly owns 44,269 shares worth $3,083,314.

Ventas, Inc. (VTR) Analyst Guide

Several analysts have released their opinion on Ventas, Inc. (NYSE:VTR), with 0 analysts believing it is a strong buy. Whereas 16 of them predict the stock is a hold. Also, there are 1 buy, 2 sell and 0 strong sell ratings, collectively assigning a 3.05 average brokerage recommendation [T1].